当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析

益丰药房

(603939)

  

流通市值:297.64亿  总市值:297.65亿
流通股本:12.12亿   总股本:12.12亿

益丰药房(603939)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润13.21亿元,每股收益1.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1188244.24万元,未分配利润576984.63万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2607138.71万元,负债1418894.47万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入17,285,899,932.6411,721,819,634.466,009,043,521.2724,062,154,701.73
营业总成本15,631,502,380.8510,538,133,417.855,391,078,498.3621,973,892,618.65
其他经营收益
营业利润1,786,801,453.441,272,348,418.64650,541,861.922,203,824,345.08
利润总额1,769,955,687.281,263,589,794.94647,828,853.772,182,447,381.72
净利润1,321,166,607.72945,793,936.37493,549,281.071,652,782,285.86
每股收益
其他综合收益47,773,490.5132,352,8259,609,750-69,190,200
综合收益总额1,368,940,098.23978,146,761.37503,159,031.071,583,592,085.86
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计15,089,934,116.4514,699,680,085.9515,875,515,074.2715,855,782,213.51
非流动资产:
非流动资产合计10,981,452,997.0511,618,536,351.3811,911,046,281.7912,118,954,736.84
资产总计26,071,387,113.526,318,216,437.3327,786,561,356.0627,974,736,950.35
流动负债:
流动负债合计10,612,983,485.7210,639,572,046.1612,103,474,750.8212,598,073,700.81
非流动负债:
非流动负债合计3,575,961,193.193,793,477,289.753,789,883,442.133,983,099,771.61
负债合计14,188,944,678.9114,433,049,335.9115,893,358,192.9516,581,173,472.42
所有者权益(或股东权益):
归属于母公司股东权益合计11,177,628,791.7611,153,968,695.5111,185,232,095.2410,725,687,023.42
股东权益合计11,882,442,434.5911,885,167,101.4211,893,203,163.1111,393,563,477.93
负债和股东权益合计26,071,387,113.526,318,216,437.3327,786,561,356.0627,974,736,950.35
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计19,349,072,108.8813,262,684,876.496,700,021,854.8425,765,047,477.14
经营活动现金流出小计17,081,861,091.0711,693,019,088.35,585,636,163.2621,543,780,392.61
经营活动产生的现金流量净额2,267,211,017.811,569,665,788.191,114,385,691.584,221,267,084.53
投资活动产生的现金流量:
投资活动现金流入小计22,618,211,396.515,337,215,954.796,051,299,343.6716,105,473,839.63
投资活动现金流出小计22,981,387,474.3415,553,160,522.976,244,952,157.9719,714,322,940.93
投资活动产生的现金流量净额-363,176,077.84-215,944,568.18-193,652,814.3-3,608,849,101.3
筹资活动产生的现金流量:
筹资活动现金流入小计1,753,0001,753,000-1,819,870,756.58
筹资活动现金流出小计2,077,528,121.251,297,144,025.24440,787,467.612,740,071,008.89
筹资活动产生的现金流量净额-2,075,775,121.25-1,295,391,025.24-440,787,467.61-920,200,252.31
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-171,740,181.2858,330,194.77479,945,409.67-307,782,269.08
期末现金及现金等价物余额1,989,057,689.242,219,128,065.292,640,743,280.192,160,797,870.52
补充资料:
现金及现金等价物的净增加额-58,330,194.77--307,782,269.08
最新报告期:2025-11-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中邮证券龙永茂1.391.601.842025-11-03
东方证券伍云飞1.431.621.822025-11-03
平安证券叶寅,倪亦道,王钰畅1.461.701.962025-11-02
中信证券宋硕,陈竹,张斌斌1.411.601.812025-10-31
东吴证券苏丰,冉胜男,朱国广1.391.611.872025-10-30
TOP↑